Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil
Heloisa Resende, Vinícius de Q Aguiar, Nataline F de A Santos, et al.
Ecancermedicalscience
|
February 28, 2024
Current scenario and future perspectives of clinical research in Brazil: a national survey
Heloisa Resende, Taiane F Rebelatto, Gustavo Werutsky, et al.
Personalized Medicine
|
July 16, 2025
Optimizing breast cancer therapy: chemoressitance and machine learning for precision prediction
Martina Lichtenfels, Matheus G S Dalmolin, Julia Caroline Marcolin, et al.
Ecancermedicalscience
|
May 22, 2024
Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023
Heloisa Resende, Roberto J Arai, Carlos H Barrios, et al.
Breast Cancer Research and Treatment
|
December 5, 2025
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer
Danielle Laperche-Santos, Daniele Assad-Suzuki, Heloisa Resende, et al.
Scientific Reports
|
January 23, 2026
Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors
Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende, et al.
JCO Global Oncology
|
April 18, 2025
Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor-Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study
Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende, et al.
JCO Global Oncology
|
October 8, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil
Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende, et al.
Cancer Medicine
|
October 30, 2025
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer
Daniele Assad-Suzuki, Luciana Castro Garcia Landeiro, Danielle Laperche-Santos, et al.
JCO Global Oncology
|
March 7, 2025
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
Alessandra Borba Anton de Souza, Carlos Barrios, Rafaela Gomes de Jesus, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Current Oncology (Toronto, Ont.)
|
August 27, 2025
Treatment Disparities, Heterogeneities, and Barriers to Access for Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A National Survey from Brazil
Heloisa Resende, Vinícius de Q Aguiar, Nataline F de A Santos, et al.
Ecancermedicalscience
|
February 28, 2024
Current scenario and future perspectives of clinical research in Brazil: a national survey
Heloisa Resende, Taiane F Rebelatto, Gustavo Werutsky, et al.
Personalized Medicine
|
July 16, 2025
Optimizing breast cancer therapy: chemoressitance and machine learning for precision prediction
Martina Lichtenfels, Matheus G S Dalmolin, Julia Caroline Marcolin, et al.
Ecancermedicalscience
|
May 22, 2024
Improving access to cancer clinical research in Brazil: recent advances and new opportunities. Expert opinions from the 4th CURA meeting, São Paulo, 2023
Heloisa Resende, Roberto J Arai, Carlos H Barrios, et al.
Breast Cancer Research and Treatment
|
December 5, 2025
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer
Danielle Laperche-Santos, Daniele Assad-Suzuki, Heloisa Resende, et al.
Scientific Reports
|
January 23, 2026
Sexual dysfunction in Brazilian women undergoing adjuvant endocrine therapy for breast cancer: prevalence and associated factors
Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende, et al.
JCO Global Oncology
|
April 18, 2025
Adherence to Adjuvant Endocrine Therapy in Patients With Nonmetastatic Estrogen Receptor-Positive Breast Cancer: A Comprehensive Brazilian Real-World Data Study
Daniele Assad-Suzuki, Danielle Laperche-Santos, Heloisa Resende, et al.
JCO Global Oncology
|
October 8, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil
Romualdo Barroso-Sousa, Danielle Laperche-Santos, Heloisa Resende, et al.
Cancer Medicine
|
October 30, 2025
Employment Status Among Brazilian Women With Estrogen Receptor-Positive Nonmetastatic Breast Cancer
Daniele Assad-Suzuki, Luciana Castro Garcia Landeiro, Danielle Laperche-Santos, et al.
JCO Global Oncology
|
March 7, 2025
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
Alessandra Borba Anton de Souza, Carlos Barrios, Rafaela Gomes de Jesus, et al.
Page
of 1